Already at best price
Myvajra Tablet
Emtricitabine (200mg) + Tenofovir disoproxil fumarate (300mg)
Laurus Labs Limited
HIV infection
₹2499.00
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
₹2499.00
Active composition
Emtricitabine 200 mg
+1 more active ingredient
How It Works
Tenofovir disoproxil fumarate is converted to tenofovir, which inhibits reverse transcriptase, blocking viral DNA synthesis.
Medicine Strength
200 mg
All Active Ingredients
Emtricitabine200 mg
Tenofovir disoproxil fumarate300 mg
Uses & Benefits
Medical applications
InfectionViral
The Myvajra Tablet is a pharmaceutical formulation containing Emtricitabine (200mg) and Tenofovir disoproxil fumarate (300mg). This combination antiretroviral medication is indicated for the treatment of HIV-1 infection in adults and adolescents who weigh at least 35 kg. Myvajra Tablets are not a cure for HIV-1, but they help control the virus by reducing the amount of HIV-1 in the body. It is essential to take Myvajra Tablets as prescribed, in combination with other antiretroviral drugs. Regular monitoring of treatment response, including viral load and CD4 cell count, is necessary. Patients should be informed about the potential benefits and risks, as well as the importance of adherence to the treatment regimen and safer sexual practices to minimize the risk of HIV transmission.
Dosage & How to Use
How to use Myvajra Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Myvajra Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
✓Only 2.3% reported effects
Common Side Effects
Headache8%
Nausea5%
Higher
Lower
Safety Advice
Alcohol
It is not known whether it is safe to consume alcohol with Myvajra Tablet. Please consult your doctor.
High Risk
Pregnancy
Myvajra Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Medical Advice
Driving
Myvajra Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Liver
Myvajra Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Myvajra Tablet may not be needed in these patients. Please consult your doctor.
Regular Checkup
Breastfeeding
Myvajra Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Kidney
Myvajra Tablet should be used with caution in patients with kidney disease. Dose adjustment of Myvajra Tablet may be needed. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Myvajra Tablet
Myvajra Tablet
Rx RequiredSchedule H
Myvajra Tablet
Emtricitabine (200mg) + Tenofovir disoproxil fumarate (300mg)
₹2499.00
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
Cheaper alternative availability
Not Foundfor this medicine
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Emtricitabine 200 mg
+1 more active ingredient
How It Works
Tenofovir disoproxil fumarate is converted to tenofovir, which inhibits reverse transcriptase, blocking viral DNA synthesis.
Medicine Strength
200 mg
All Active Ingredients
Emtricitabine200 mg
Tenofovir disoproxil fumarate300 mg
Uses & Benefits
Medical applications
InfectionViral
The Myvajra Tablet is a pharmaceutical formulation containing Emtricitabine (200mg) and Tenofovir disoproxil fumarate (300mg). This combination antiretroviral medication is indicated for the treatment of HIV-1 infection in adults and adolescents who weigh at least 35 kg. Myvajra Tablets are not a cure for HIV-1, but they help control the virus by reducing the amount of HIV-1 in the body. It is essential to take Myvajra Tablets as prescribed, in combination with other antiretroviral drugs. Regular monitoring of treatment response, including viral load and CD4 cell count, is necessary. Patients should be informed about the potential benefits and risks, as well as the importance of adherence to the treatment regimen and safer sexual practices to minimize the risk of HIV transmission.
Dosage & How to Use
How to use Myvajra Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Myvajra Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
✓Only 2.3% reported effects
Common Side Effects
Headache8%
Nausea5%
Higher
Lower
Safety Advice
Alcohol
It is not known whether it is safe to consume alcohol with Myvajra Tablet. Please consult your doctor.
High Risk
Pregnancy
Myvajra Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Medical Advice
Driving
Myvajra Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Liver
Myvajra Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Myvajra Tablet may not be needed in these patients. Please consult your doctor.
Regular Checkup
Breastfeeding
Myvajra Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Kidney
Myvajra Tablet should be used with caution in patients with kidney disease. Dose adjustment of Myvajra Tablet may be needed. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Myvajra Tablet
